D L Mayers - JoVE Visualize

Showing results (11-20 of 29) with videos related to

Pageof 3

Sort By:

Antiviral Therapy|June 10, 2000

Frequency of antiretroviral drug resistance mutations in HIV-1 strains from patients failing triple drug regimens. The Terry Beirn Community Programs for Clinical Research on AIDSM A Winters, J D Baxter, D L Mayers, et al.

Antimicrobial Agents and Chemotherapy|May 1, 1995

Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolatesJ W Mellors, H Z Bazmi, R F Schinazi, et al.

Archives of Internal Medicine|April 12, 1993

CD4 lymphocyte counts within 24 months of human immunodeficiency virus seroconversion. Findings in the US Navy and Marine Corps. The Navy Retroviral Working GroupE D Gorham, F C Garland, D L Mayers, et al.

Journal of Clinical Microbiology|March 1, 1997

Standardized peripheral blood mononuclear cell culture assay for zidovudine susceptibility testing of clinical human immunodeficiency virus type 1 isolates: effect of reducing the numbers of replicates and concentrationsI C Marschner, D L Mayers, A Erice, et al.

The Journal of Infectious Diseases|October 1, 1995

Quantitative relationship of circulating p24 antigen with human immunodeficiency virus (HIV) RNA and specific antibody in HIV-infected subjects receiving antiretroviral therapy. The RV43 Study GroupA E Brown, M T Vahey, S Y Zhou, et al.

JAMA|December 8, 1989

Incidence of human immunodeficiency virus seroconversion in US Navy and Marine Corps personnel, 1986 through 1988F C Garland, D L Mayers, T M Hickey, et al.

Antimicrobial Agents and Chemotherapy|February 1, 1994

Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study GroupD L Mayers, A J Japour, J M Arduino, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996

Intact antigen receptor-mediated calcium signals in patients with early stage HIV-1 infectionT E Hickey, P J Blair, S Perfetto, et al.

Controlled Clinical Trials|April 18, 2001

The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trialR D MacArthur, L Chen, D L Mayers, et al.

Antimicrobial Agents and Chemotherapy|May 1, 1993

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working GroupA J Japour, D L Mayers, V A Johnson, et al.

Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:

Pageof 3

Antiviral Therapy|June 10, 2000

Frequency of antiretroviral drug resistance mutations in HIV-1 strains from patients failing triple drug regimens. The Terry Beirn Community Programs for Clinical Research on AIDSM A Winters, J D Baxter, D L Mayers, et al.

Antimicrobial Agents and Chemotherapy|May 1, 1995

Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolatesJ W Mellors, H Z Bazmi, R F Schinazi, et al.

Archives of Internal Medicine|April 12, 1993

CD4 lymphocyte counts within 24 months of human immunodeficiency virus seroconversion. Findings in the US Navy and Marine Corps. The Navy Retroviral Working GroupE D Gorham, F C Garland, D L Mayers, et al.

Journal of Clinical Microbiology|March 1, 1997

Standardized peripheral blood mononuclear cell culture assay for zidovudine susceptibility testing of clinical human immunodeficiency virus type 1 isolates: effect of reducing the numbers of replicates and concentrationsI C Marschner, D L Mayers, A Erice, et al.

The Journal of Infectious Diseases|October 1, 1995

Quantitative relationship of circulating p24 antigen with human immunodeficiency virus (HIV) RNA and specific antibody in HIV-infected subjects receiving antiretroviral therapy. The RV43 Study GroupA E Brown, M T Vahey, S Y Zhou, et al.

JAMA|December 8, 1989

Incidence of human immunodeficiency virus seroconversion in US Navy and Marine Corps personnel, 1986 through 1988F C Garland, D L Mayers, T M Hickey, et al.

Antimicrobial Agents and Chemotherapy|February 1, 1994

Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study GroupD L Mayers, A J Japour, J M Arduino, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996

Intact antigen receptor-mediated calcium signals in patients with early stage HIV-1 infectionT E Hickey, P J Blair, S Perfetto, et al.

Controlled Clinical Trials|April 18, 2001

The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trialR D MacArthur, L Chen, D L Mayers, et al.

Antimicrobial Agents and Chemotherapy|May 1, 1993

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working GroupA J Japour, D L Mayers, V A Johnson, et al.

Pageof 3